Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Cancer Cell Biology (111201)"

Subjects classification (33141)
- Australian and New Zealand Standard Research Classification (33141)
  - MEDICAL AND HEALTH SCIENCES (110000) (6832)
    - ONCOLOGY AND CARCINOGENESIS (111200) (353)
      - Cancer Cell Biology (111201) (86)

Group by: Authors/Creators | Item Type

Jump to: A | B | C | D | F | G | H | I | J | L | M | N | O | P | Q | R | S | T | U | W | Y

Number of items at this level: 86.

A

Adamson, R.E., Frazier, A.A., Evans, H., Chambers, Karen F., Schenk, E., Essand, M., et al. (2012) In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus. Human Gene Therapy, 23(2), pp. 218-230.

Amin Al Olama, A., Kote-Jarai, Z., Schumacher, F. R., Wiklund, F., Berndt, S. I., Benlloch, S., et al. (2012) A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics, 22(2), pp. 408-415.

B

Batra, J., O'Mara, T., Lose, F., & Clements, J.A. (2012) Single nucleotide polymorphisms in the KLK locus and their implication in various diseases. In Schmitt, M., Magdolen, V., Sommerhoff, C., & Fritz, H. (Eds.) Kallikrein-related peptidases [Volume 1]: Characterization, regulation, and interactions. DeGruyter, Berlin, pp. 31-78.

Batra, Jyotsna, O’Mara, Tracy, Patnala, Radhika, Lose, Felicity, & Clements, Judith A. (2012) Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases. Biological Chemistry, 393(12), pp. 1365-1390.

Battula, VL, Evans, KW, Hollier, Brett G., Shi, Y, Marini, FC, Ayyanan, A, et al. (2010) Epithelial-mesenchymal transition derived cells exhibit multi lineage differentiation potential similar to mesenchymal stem cells. Stem Cells, 28(8), pp. 1435-1445.

Bennett, Nigel, Hooper, John, Soon Lee, C, & Gobe, Glenda (2009) Androgen receptor and caveolin-1 in prostate cancer. IUBMB Life, 61(10), pp. 961-970.

Betsou, Fotini, Gunter, Elaine, Clements, Judith, DeSouza, Yvonne, Goddard, Katrina A.B., Guadagni, Fiorella, et al. (2013) Identification of evidence-based biospecimen quality-control tools. The Journal of Molecular Diagnostics, 15(1), pp. 3-16.

Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406(6795), pp. 536-540.

1,242

1,190

Busacca, Sara, Sheaff, Michael, Arthur, Kenneth, Gray, Steven G, O'Byrne, Kenneth J, Richard, Derek J., et al. (2012) BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. The Journal of Pathology, 227(2), pp. 200-208.

Byron, Sara A. & Pollock, Pamela M. (2009) FGFR2 as a molecular target in endometrial cancer. Future Oncology, 5(1), pp. 27-32.

C

Castellano, Marina, Pollock, Pamela M., Walters, Marilyn K., Sparrow, Louise E., Down, Louise M., Gabrielli, Brian G., et al. (1997) CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Research, 57(21), pp. 4868-4875.

Chopin, L. K., Seim, I., Walpole, C. M., & Herington, A. C. (2012) The Ghrelin axis : does it have an appetite for cancer progression? Endocrine Reviews, 33(6), pp. 849-891. (In Press)

Cook, Anthony L., Pollock, Pamela M., Welch, John, Walsh, Michael D., Bowman, Rayleen V., Baumann, Kathryn C., et al. (2001) CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin. International Journal of Cancer, 93(3), pp. 361-367.

Cubeddu, Liza, Joseph, Soumya, Richard, Derek J., & Matthews, Jacqueline M. (2012) Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4. PLoS ONE, 7(6), e39218.

D

Dalley, Andrew J., AbdulMajeed, Ahmad A., Upton, Zee, & Farah, Camile S. (2013) Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75(NTR) in malignancy. Journal Of Oral Pathology & Medicine, 42(1), pp. 37-46.

Deryugina, Elena, Conn, Erin, Wortmann, Andreas, Partridge, Juneth, Kupriyanova, Tatyana, Ardi, Veronica, et al. (2009) Functional role of cell surface CUB domain-containing protein 1 in tumour cell dissemination. Molecular Cancer Research, 7(8), pp. 1197-1211.

Dong, Ying, Loessner, Daniela, Sieh, Shirly, Taubenberger, Anna V., Fuhrman-Luck, Ruth, Magdolen, V., et al. (2012) Cellular model systems to study the tumor biological role of kallikrein-related peptidases in ovarian and prostate cancer. In Schmitt, M., Magdoen, V., Somerhoff, C., & Fritz, H. (Eds.) Kallikrein-related peptidases [Volume 2] : Novel cancer-related biomarkers. deGruyter, Berlin, pp. 83-110.

de Souza, Paul, Russell, Pamela, Kearsley, John, & Howes, Laurence (2010) Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutrition Reviews, 68(9), pp. 542-555.

F

Flores, Jose F., Pollock, Pamela M., Walker, Graeme J., Glendening, J. Michael, Lin, Amy H-T, Palmer, Jane M., et al. (1997) Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds. Oncogene, 15(24), pp. 2999-3005.

Foulkes, William D., Flanders, Tamar Y., Pollock, Pamela M., & Hayward, Nicholas K. (1997) The CDKN2A (p16) gene and human cancer. Molecular Medicine, 3(1), pp. 5-20.

101

111

G

Grimmond, S., Lagercrantz, J., Drinkwater, C., Silins, G., Townson, S., Pollock, P.M., et al. (1996) Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Research, 6(2), pp. 124-131.

Gunter, Jennifer H., Lubik, Amy A., McKenzie, Ian, Pollak, Michael, & Nelson, Colleen C. (2012) The interactions between insulin and androgens in progression to castrate resistant prostate cancer. Advances in Urology, 2012, pp. 1-11.

Gunter, Jennifer H., Sarkar, Phoebe L., Lubik, Amy A., & Nelson, Colleen C. (2013) New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication. International Journal of Cell Biology, 2013(2013), pp. 1-13.

H

Hacker, Elke, Muller, Konrad, Hayward, Nicholas K., Fahey, Paul, & Walker, Graeme J. (2010) Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4R24C/R24C/Tyr-NrasQ61K mice following neonatal UVR. Pigment Cell and Melanoma Research, 23(1), pp. 121-128.

Herington, Adrian & Lobie, Peter (2012) Signal transduction mechanisms underlying growth hormone receptor action. The Open Endocrinology Journal, 6(1), pp. 13-21.

Hollier, B.G., Tinnirello, A.A., Werden, S.J., Evans, K., Taube, J.H., Sarkar, T.R., et al. (2013) FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Research. (In Press)

Hollier, Brett G., Evans, KW, & Mani, SA (2009) The epithelial-to-mesenchymal transition and cancer stem cells : a coalition against cancer therapies. Journal of Mammary Gland Biology and Neoplasia, 14(1), pp. 29-43.

102

Husaini, Yasmin, Qiu, Min Ru, Lockwood, Glen P., Luo, Xu Wei, Shang, Ping, Kuffner, Tamara, et al. (2012) Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice. PLoS ONE, 7(8), e43833.

I

Inder, Kerry L, Zheng, Yu Zi, Davis, Melissa J, Moon, Hyeongsun, Loo, Dorothy, Nguyen, Hien, et al. (2012) Expression of PTRF in PC3 cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways. Molecular and Cellular Proteomics, 11(2).

J

Jeet, Varinder, Russell, Pamela, & Khatri, Aparajita (2010) Modeling prostate cancer: a perspective on transgenic mouse models. Cancer and Metastasis Reviews, 29(1), pp. 123-142.

Jeet, Varinder, Russell, Pamela J., Verma, Nirupama D., & Khatri, Aparajita (2012) Targeting aurora kinases : a novel approach to curb the growth and chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), pp. 144-163.

Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.

L

Lawrence, M.G., Stephens, C.R., Need, E.F., Lai, J., Buchanan, G., & Clements, J.A. (2012) Long terminal repeats act as androgen-responsive enhancers for the PSA-Kallikrein locus. Endocrinology, 153(7), pp. 3199-3210.

Lisle, JE, Mertens-Walker, I, Stephens, CR, Stansfield, SH, Harris, JM, Clements, JA, et al. (2013) Kallikrein-related peptidase 4 initiates cleavage of the tumor promoting receptor tyrosine kinase. PLoS ONE.

Locke, Jennifer, Fazli, Ladan, Adomat, Hans, Smyl, Jil, Weins, Kristin, Lubik, Amy, et al. (2009) A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer. The Prostate, 69(9), pp. 928-937.

Locke, Jennifer, Nelson, Colleen, Adomat, Hans, Hendy, Stephen, Gleave, Martin, & Tomlinson-Guns, (2009) Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostrate xenografts. Journal of Steroid Biochemistry and Molecular Biology, 115(NA), pp. 126-136.

Locke, Jennifer, Tomlinson Guns, Emma, Lehman, Melanie, Ettinger, Susan, Zoubeidi, Amina, Lubik, Amy, et al. (2010) Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance. The Prostate, 70(3), pp. 239-251.

Loessner, Daniela, Stok, Kathryn S., Lutolf, Mathias E., Hutmacher, Dietmar W., Clements, Judith A., & Rizzi, Simone C. (2010) Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials, 31(32), pp. 8494-8506.

194

Lose, Felicity, Lawrence, Mitchell Graham, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, et al. (2012) Kallikrein 14 is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness. Biological Chemistry, 393(5), pp. 403-412.

Lubik, Amy, Gunter, Jennifer, Hollier, Brett G., Fazli, Ladan, Ettinger, Susan, Stylianou, Nataly, et al. (2012) Insulin-like growth factor-2 increases de novo steroidogenesis in prostate cancer cells. Endocrine Related Cancer. (In Press)

M

Maitland, Norman, Chambers, Karen F., Georgopoulos, Lindsay, Simpson-Holley, Martha, Leadley, Regina, Evans, Helen, et al. (2010) Gene transfer vectors targeted to human prostate cancer : do we need better preclinical testing systems? Human Gene Therapy, 21(7), pp. 815-827.

Mani, S.A., Evans, K.W., Hollier, B.G., Guo, W., & Weinberg, R.A. (2009) Generation of stem-like cells via EMT; a new twist in cancer initiation and progression. In American Association of Cancer Research (AACR) Education Book. American Association of Cancer Research (AACR) .

N

Nelson, Colleen (2012) Complexity of androgen action in prostate cancer progression. In The 15th International Congress on Hormonal Steroids and Hormones & Cancer, 15-17 November 2012, Ishikawa Ongakudo, Japan.

Nickoloff, Brian J., Hendrix, Mary J.C., Pollock, Pamela M., Trent, Jeffrey M., Miele, Lucio, & Qin, Jian-Zhong (2005) Notch and NOXA-related pathways in melanoma cells. Journal of Investigative Dermatology Symposium Proceedings, 10(2), pp. 95-104.

O

O'Mara, Tracy, Clements, Judith, & Spurdle, Amanda (2009) The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors. Cancer Epidemiology Biomarkers and Prevention, 18(9), p. 2352.

O’Flaherty, John D., Barr, Martin, Fennell, Dean, Richard, Derek, Reynolds, John, O’Leary, John, et al. (2012) The cancer stem-cell hypothesis : its emerging role in lung cancer biology and its relevance for future therapy. Journal of Thoracic Oncology, 7(12), pp. 1880-1890.

O’Flaherty, John D., Gray, Steven, Richard, Derek J., Fennell, Dean, O’Leary, John J., Blackhall, Fiona H., et al. (2012) Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer, 76(1), pp. 19-25.

P

Pagan, Julia K., Bolderson, Emma, Jones, Mathew J. K., & Khanna, Kum Kum (2009) Chromatin modifications involved in the DNA damage response to double strand breaks. In Khanna, Kum Kum & Shiloh, Yosef (Eds.) The DNA Damage Response: Implications on Cancer Formation and Treatment. Springer, pp. 109-131.

Pavey, Sandra, Johansson, Peter, Packer, Leisl, Taylor, Jennifer, Stark, Mitchell, Pollock, Pamela M., et al. (2004) Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene, 23(23), pp. 4060-4067.

102

Pollock, P.M., Cohen-Solal, K., Sood, R., Namkoong, J., Martino, J.J., Koganti, A., et al. (2003) Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nature Genetics, 34(1), pp. 108-112.

Pollock, P.M., Harper, U.L., Hansen, K.S., Yudt, L.M., Stark, M., Robbins, C.M., et al. (2003) High frequency of BRAF mutations in nevi. Nature Genetics, 33(1), pp. 19-20.

705

670

Pollock, P.M. & Trent, J.M. (2000) The genetics of cutaneous melanoma. Clinics in Laboratory Medicine, 20(4), pp. 667-690.

Pollock, P.M., Walker, G.J., Glendening, J.M., Que Noy, T., Bloch, N.C., Fountain, J.W., et al. (2002) PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Melanoma Research, 12(6), pp. 565-575.

Pollock, Pamela M. & Hayward, Nicholas K. (2002) Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Research, 12(2), pp. 183-186.

Pollock, Pamela M. & Meltzer, Paul S. (2002) Lucky draw in the gene raffle. Nature, 417(6892), pp. 906-907.

Pollock, Pamela M. & Meltzer, Paul S. (2002) A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell, 2(1), pp. 5-7.

Pollock, Pamela M., Pearson, John V., & Hayward, Nicholas K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers : non-random distribution of base substitutions. Genes Chromosomes and Cancer, 15(2), pp. 77-88.

148

162

Pollock, Pamela M., Spurr, Nigel, Bishop, Tim, Newton-Bishop, Julia, Gruis, Nelleke, van der Velden, Pieter A., et al. (1998) Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families : evidence for common founders and independent mutations. Human Mutation, 11(6), pp. 424-431.

Pollock, Pamela M., Welch, John, & Hayward, Nicholas K. (2001) Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Research, 61, pp. 1154-1161.

Q

Qin, Jian-Zhong, Stennett, Lawrence, Bacon, Patricia, Bodner, Barbara, Hendrix, Mary J.C., Seftor, Richard E.B., et al. (2004) p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Molecular Cancer Therapeutics, 3(8), pp. 895-902.

R

Ramsay, Andrew, Hooper, John, Folgueras, Alicia, Velasco, Gloria, & Lopez-Otin, Carlos (2009) Matriptase-2 (TMPRSS6): a proteplytic regulator of iron homeostasis. Haematologica, 94(6), pp. 840-849.

Read, Jason, Cheng, Helen, Hendy, Stephen, Nelson, Colleen, & Rennie, Paul (2009) Receptor-DNA interactions: EMSA and footprinting. Methods in Molecular Biology, 505(1), pp. 97-122.

Reichert, Johannes C., Quent, Verena M. C, Burke, Leslie J., Stansfield, Scott H., Clements, Judith A., & Hutmacher, Dietmar W. (2010) Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials, 31, pp. 7928-7936.

Rutowski, Raphael, Mertens-Walker, Inga, Lisle, Jessica E, Herington, Adrian C., & Stephenson, Sally-Anne (2012) Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. International Journal of Cancer, 131(5), E614-E624.

S

Sanchez, Washington Y., de Veer, Simon J., Swedberg, Joakim E., Hong, Eui-Ju, Reid, Janet C., Walsh, Terry P., et al. (2012) Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells. Endocrinology, 153(7), pp. 3179-3189.

Scott, Kieran, Sajinovic, Mila, Hein, Juliane, Nixdorf, Sheri, Galettis, Peter, Liauw, Winston, et al. (2010) Emerging roles for phospholipase A2 enzymes in cancer. Biochimie, 92(6), pp. 601-610.

Seim, Inge, Lubik, Amy A., Lehman, Melanie, Tomlinson, N., Whiteside, Eliza J., Herington, Adrian C., et al. (2012) Cloning of a novel insulin-regulated ghrelin transcript in prostate cancer. Journal of Molecular Endocrinology.

Sieh, Shirly, Reichert, Johannes C., Lubik, Amy, Clements, Judith, Colleen, Nelson, & Hutmacher, Dietmar W. (2009) Implication of 3D culture system for study of prostate cancer (CaP) mediated bone metastasis. In Second Asian Biomaterials Congress, 26-27 June 2009, National University of Singapore, Singapore. (Unpublished)

224

Snoek, Robert, Cheng, Helen, Margiotti, Katia, Wafa, Latif, Wong, Charmaine, Chan Wong, Erica, et al. (2009) In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumours. Clinical Cancer Research, 15(1), pp. 39-47.

Stephenson, Sally-Anne, Mertens-Walker, Inga, & Herington, Adrian (2012) Signaling of receptor tyrosine kinases in the nucleus. In Najman, Stevo (Ed.) Current Frontiers and Perspectives in Cell Biology. InTech, Rijeka, Croatia, pp. 211-234.

Sun, Sophie, Pollock, Pamela M., Liu, Ling, Karimi, Sepideh, Jothy, Serge, Milner, Benedict J., et al. (1997) CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein. International Journal of Cancer, 73(4), pp. 531-536.

Swedberg, Joakim, Nigon, Laura, Reid, Janet, De Veer, Simon, Walpole, Carina, Stephens, Carson, et al. (2009) Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. Chemistry & Biology, 16(6), pp. 633-643.

T

Tang, Catherine, Russell, Pamela, Martiniello-Wilks, Rosetta, Rasko, John, & Khatri, Aparajita (2010) Concise Review: Nanoparticles and cellular carriers - allies in cancer imaging and cellular gene therapy? Stem Cells, 28(9), pp. 1686-1702.

Taube, JH, Herschkowitz, J, Komurov, K, Zhou, AY, Gupta, S, Yang, J, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490, 107(35), pp. 15449-15454.

139

128

Thurber, A. E., Douglas, G., Sturm, E. C., Zabierowski, S. E., Smit, D. J., Ramakrishnan, S. N., et al. (2011) Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene, 30(27), pp. 3036-3048.

Tse, Brian Wan-Chi, Scott, Kieran F, & Russell, Pamela J. (2012) Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer, 2012, pp. 1-8.

U

Uemura, Hirotsugu, Nelson, Colleen, Schalken, Jack A., & Klotz, Laurence (2012) Personalized cancer therapy for urological cancers: From bench to bedside and back. Advances in Urology, 2012(2012), pp. 1-2.

W

Wagholikar, Amol, Fung, Maggie, & Nelson, Colleen (2012) Improving self care of patients with chronic disease using online personal health record. Australasian Medical Journal, 5(9), pp. 517-521.

Walia, V., Yu, Y., Cao, D., Sun, M., McLean, J.R., Hollier, B.G., et al. (2012) Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis. Oncogene, 31(17), pp. 2237-2246.

Walker, Graeme J., Indsto, James O., Sood, Raman, Faruque, Mezbah U., Hu, Ping, Pollock, Pam M., et al. (2004) Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer, 41(1), pp. 56-64.

Wang, Qian, Tiffen, Jessamy, Bailey, Charles G., Lehman, Melanie, Ritchie, William, Fazli, Ladan, et al. (2013) Targeting amino acid transport in metastatic castration-resistant prostate cancer suppresses cell cycle, cell growth and tumor development. .

Wilkinson, Ray, Woods, Katherine, D'Rozario, Rachael, Prue, Rebecca, Vari, Frank, Hardy, Melinda Y, et al. (2012) Human Kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients. Cancer Immunology Immunotherapy, 61(2), pp. 169-179.

Wortmann, Andreas, He, Yaowu, Christensen, Melinda E., Linn, MayLa, Lumley, John W., Pollock, Pamela M., et al. (2011) Cellular settings mediating Src Substrate switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734. Journal of Biological Chemistry, 286(49), pp. 42303-42315.

Wortmann, Andreas, He, Yaowu, Deryugina, Elena, Quigley, James, & Hooper, John (2009) The cell surface glycoprotein CDCP1 in cancer - insights, opportunities and challenges. IUBMB Life, 61(7), pp. 723-730.

Y

Yao, Y., Abbruzzese, J., Asano, T., Chang, B., Hollier, B.G., Chien-Hung, C., et al. (2013) BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte Differentiation. Science Signalling, 6(257).

Yi, Y, Srinivas, Nandana, Case, Thomas, Nelson, Colleen, Radmilovic, T, Matusik, Robert, et al. (2009) Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer. Molecular Cytogenetics, 2(18), pp. 1-9.

This list was generated on Sat Jun 15 09:20:01 2013 EST.

Export as	RSS 1.0 Atom RSS 2.0